Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q4 2025
Institutional positions in Verona Pharma plc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
VRNA is no longer listed, and 13F filings after Q3 2025 list far fewer holders. See Q3 2025
- Institutional holders
- 1
- −238 vs. Q3 2025
- Shares held
- 20.0K
- −80.1M (−100.0%) vs. Q3 2025
- Total value
- $359.0K
- −$8.55B (−100.0%) vs. Q3 2025
- New holders
- 0
- 0 more added
- Sold out
- 238
- 0 more reduced
4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,974−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −1,935−100.0% | Sold out |
| Keel Point, LLC | 0 | $0 | 0.00% | −1,875−100.0% | Sold out |
| GF Fund Management Co. Ltd. | 0 | $0 | 0.00% | −1,826−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −1,528−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −1,104−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −1,077−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −1,007−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −962−100.0% | Sold out |
| Longfellow Investment Management Co LLC | 0 | $0 | 0.00% | −713−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −596−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Main Street Group, LTD | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −399−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −375−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −343−100.0% | Sold out |
| Capital Analysts, LLC | 0 | $0 | 0.00% | −318−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −269−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −210−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −169−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| WPG Advisers, LLC | 0 | $0 | 0.00% | −154−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −137−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −93−100.0% | Sold out |
| Global Wealth Strategies & Associates | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| ORG Partners LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Blue Owl Capital Holdings LP | 0 | $0 | 0.00% | −18,347−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Burren Capital Advisors Ltd | – | – | – | – | Not filed |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Wolverine Trading, LLC | – | – | – | – | Not filed |